(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLD, CRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network!. Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Bullish Views for XPeng and Blueprint Medicines

  • August 21st, 2023
  • 453 views

XPeng Inc. (NYSE: XPEV), a leading Chinese electric vehicle manufacturer, received a boost in investor sentiment as BofA Securities upgraded the company from Neutral to Buy and raised the price target from $16.30 to $22.00.

Considering that $XPEV closed at $14.98 on Friday, the adjusted price target indicates a potential upside of $7.02 or approximately 46.83%, based on the financial advisory firm's assessment

In other news, Blueprint Medicines Corporation (Nasdaq: BPMC) continues to receive a favorable evaluation from Needham, as the brokerage firm maintained its Buy rating and raised the price target from $65 to $66.

Based on Friday's closing price of $49.29, the updated price target implies a potential upside of $16.71 or approximately 33.88% for $BPMC, according to Needham's analysis.

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)

Tags

Social Shares

Post Your Comments

Want To Find Some News?

Recent Posts

News By Industries

Tags